Dr. Shashank Teotia, CHRO, Paras Health, is a strategic human capital leader with over 22 years of experience across healthcare, edtech, ecommerce, insurance, FMCG and retail. He specialises in organisation design, culture building and leadership
Shilpa Medicare, Eight Observations, Unit IV, Jadcherla Telangana, Ten-Day Inspection, Sterile Injectables, Oral Tablets, Capsule Production, Regulatory Approvals, US Sales, Key Agencies, Consolidated Profit
The Central Drugs Standard Control Organisation (CDSCO) has informed procurement agencies, including hospitals, that a license from Indian licensing authorities must be obligatory for acquiring devices, with additional certifications required beyond
Roche has received conditional marketing approval in Europe for Lunsumio, a new subcutaneous form of its bispecific antibody that can be administered in a quick, one?minute injection. This approval marks one of the significant changes in the...
Tesaro, Inc., a GSK subsidiary, announces that it has filed a lawsuit against AnaptysBio, Inc. in the Delaware Chancery Court. This action asserts that recent behavior of AnaptysBio significantly violates the current licensing agreement with Tesaro
Ramaiah Memorial Hospital and Ramaiah Medical College became the center of global medical innovation with the inauguration of the Worldwide Network for Blood and Marrow Transplantation (WBMT) Symposium on Cell Therapy
Actimed Therapeutics today announced a licensing agreement with Mankind Pharma, giving the company exclusive rights to develop and commercialise Actimed’s products for the treatment and prevention of cachexia across India and several South Asian...
GSK and the Fleming Initiative have declared six new antimicrobial resistance (AMR) research programmes to help in reducing the increase of drug-resistant infections. The announcement follows the WHO GLASS report of October 2025 which estimates that
In a remarkable humanitarian initiative, the 14th edition of the free Plastic Surgery Camp, organized by Akums, in collaboration with Rotary International Club and Interplast Germany, has once again ignited hope among hundreds of underserved patients
.png)
Eli Lilly and Company (India) Pvt. Ltd. has obtained CDSCO marketing approval for donanemab. The medication provides an alternative therapy to adults experiencing early symptomatic Alzheimer disease...
, CDSCO.jpg)